icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
The global investment case for hepatitis C elimination
 
 
  "......most remarkable medical breakthroughs in recent times.....a cure for hepatitis C"
 
Download the PDF here
 
Professor Margaret Hellard Burnet Institute and The Alfred Hospital
 
EASL 2019 April 10-14 Vienna
 
Reported by Jules Levin
 
EASL 2019 April 10-14 Vienna
 
Reported by Jules Levin
 
from Jules: we re not doing well in the USA or globally at thus time in the effort to eliminate HCV. In the USA progress is so slow its unlikely elimination will ever occur, see poster at EASL I reported on global elimination efforts by country and the US is ranked very low. The federal government has not responded, there is no national funded ended effort to screen, link and treat; there are a few state efforts some of which have improved their situation - some may or may not pan out, but only a few; and globally although there is an effort as evidenced by this presentation & there was a lot of attention at EASL about this, at this time the overall elimination effort lacks funding and has many obstacles and barriers, a gigantic effort. Many others have expressed they are embarrassed by the US lack of response and are not encouraged about global elimination.

0416191

0416192

0416193

0416194

0416195

0416196

0416197

0416198

0416199

04161910

04161911

04161912

04161913

04161914

04161915